The routes to orphan drug designation--our recent experience at the FDA.
Daniel
D
Lev
Chandana
C
Thorat
Ian
I
Phillips
Mathew
M
Thomas
Menfo A
MA
Imoisili
D000818:Animals; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015195:Drug Design; D006801:Humans; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration